Improvement of Insulin Sensitivity After Peroxisome Proliferator-activated Receptor-alpha Agonist Treatment is Accompanied by Paradoxical Increase of Circulating Resistin Levels.
From: Third Department of Medicine, First Faculty of Medicine and General University Hospital, Charles University, 128 08 Prague, Czech Republic. mhalu@lf1.cuni.cz
Endocrinology
- Publish Date: Sep 2006
- ISSN: 0013-7227
- Volume: 147
- Issue: 9
- Pages: 4517-24
- Medium: Print
- Language: English
- Citation (JAMA): Haluzik M M, Lacinova Z, Dolinkova M, et al. Improvement of Insulin Sensitivity After Peroxisome Proliferator-activated Receptor-alpha Agonist Treatment is Accompanied by Paradoxical Increase of Circulating Resistin Levels.. Endocrinology Sep 2006;147:4517-24
Abstract
We studied the effect of peroxisome proliferator-activated receptor-alpha (PPAR-alpha) activation on serum concentrations and tissue expression of resistin, adiponectin, and adiponectin receptor-1 and -2 (AdipoR1 and AdipoR2) mRNA in normal mice and mice with insulin resistance induced by lipogenic, simple-carbohydrate diet (LD). Sixteen weeks of LD feeding induced obesity with liver steatosis and increased insulin levels but did not significantly affect circulating adiponectin or resistin. Treatment with PPAR-alpha agonist fenofibrate decreased body weight and fat pad weight and ameliorated liver steatosis in LD-fed mice with concomitant reduction in blood glucose, free fatty acid, triglyceride, serum insulin levels, and homeostasis model assessment index values. Euglycemic-hyperinsulinemic clamp demonstrated the development of whole-body and liver insulin resistance in LD-fed mice, which were both normalized by fenofibrate. Fenofibrate treatment markedly increased circulating resistin levels on both diets and adiponectin levels in chow-fed mice only. Fat adiponectin mRNA expression was not affected by fenofibrate treatment. Resistin mRNA expression increased in subcutaneous but not gonadal fat after fenofibrate treatment. In addition to fat, a significant amount of adiponectin mRNA was also expressed in the muscle. This expression markedly increased after fenofibrate treatment in chow- but not in LD-fed mice. Adipose tissue expression of AdipoR1 mRNA was significantly reduced in LD-fed mice and increased after fenofibrate treatment. In conclusion, PPAR-alpha activation ameliorated the development of insulin resistance in LD-fed mice despite a major increase in serum resistin levels. This effect could be partially explained by increased AdipoR1 expression in adipose tissue after fenofibrate treatment.
Mesh Headings (Keywords): Adiponectin, Adipose Tissue, Animals, Blood Glucose, Diet, Dietary Carbohydrates, Fatty Acids, Nonesterified, Fatty Liver, Gene Expression, Glucose Clamp Technique, Insulin, Insulin Resistance, Lipids, Liver, Male, Mice, Mice, Inbred C57BL, Muscle, Skeletal, Obesity, Organ Size, PPAR alpha, Procetofen, RNA, Messenger, Receptors, Adiponectin, Receptors, Cell Surface, Resistin, Triglycerides, Weight Loss
Check for Full Text / PubMed Unique Identifier (PMID): 16740970
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.